| s5566 |
Dapagliflozin propanediol monohydrate |
Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors. |
Selective |
|
| S4431 |
Ertugliflozin L-pyroglutamic acid |
Ertugliflozin (MK-8835, PF-04971729) L-pyroglutamic acid is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2) with IC50 of 0.877 nM for h-SGLT2. Ertugliflozin has the potential for the treatment of type 2 diabetes mellitus. |
Selective |
h-SGLT2, IC50: 0.877 nM |
| S5413 |
Ertugliflozin |
Ertugliflozin (MK-8835, PF-04971729) is a potent and selective sodium-dependent glucose cotransporter 2 inhibitor with IC50 values of 0.877 nM for h-SGLT2 and 1000-fold higher for h-SGLT1. |
Selective |
hSGLT2, IC50: 0.877 nM |
| S1548 |
Dapagliflozin |
Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM, exhibiting 1200-fold selectivity over hSGLT1. Phase 4. |
Selective |
hSGLT2, EC50: 1.1 nM |
| S8103 |
Sotagliflozin |
Sotagliflozin is an oral dual SGLT1/SGLT2 inhibitor with IC50 of 36 nM and 1.8 nM, respectively. Phase 3.
|
Selective |
SGLT2, IC50: 1.8 nM |
| S5901 |
Canagliflozin hemihydrate |
Canagliflozin hemihydrate is the hemihydrate form of canagliflozin, which is a SGLT2 inhibitor with IC50 of 2.2 nM for hSGLT2 in a cell-free assay, exhibits 413-fold selectivity over hSGLT1. |
Selective |
mSGLT2, IC50: 2 nM; hSGLT2, IC50: 4.4 nM |
| S2760 |
Canagliflozin (JNJ 28431754) |
Canagliflozin (TA 7284, JNJ 28431754) is a highly potent and selective SGLT2 inhibitor for hSGLT2 with IC50 of 2.2 nM in a cell-free assay, exhibits 413-fold selectivity over hSGLT1. |
Selective |
hSGLT2, IC50: 4.4 nM; rSGLT2, IC50: 3.7 nM; mSGLT2, IC50: 2 nM |
| S8558 |
Tofogliflozin(CSG 452) |
Tofogliflozin (CSG 452) is a novel sodium-glucose co-transporter 2(SGLT2) inhibitor with IC50 values of 2.9 nM and 8444 nM for hSGLT2 and hSGLT1, respectively.
|
Selective |
hSGLT2, IC50: 2.9 nM |
| S8022 |
Empagliflozin |
Empagliflozin is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3. |
Selective |
SGLT2, IC50: 3.1 nM |
| S8637 |
Ipragliflozin (ASP1941) |
Ipragliflozin (ASP1941) is a highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor with an IC50 value of 7.4 nM for hSGLT2 and a 254-fold selectivity versus SGLT1.
|
Selective |
hSGLT2, IC50: 7.4 nM; rat SGLT2, IC50: 6.73 nM; mouse SGLT2, IC50: 5.64 nM |
| S0994 |
Ipragliflozin L-Proline |
Ipragliflozin L-Proline is an orally active and selective inhibitor of SGLT2 with IC50 of 7.38 nM, 6.73 nM and 5.64 nM for human SGLT2, rat SGLT2 and mouse SGLT2, respectively. |
Selective |
human SGLT2, IC50: 7.38 nM; rat SGLT2, IC50: 6.73 nM; mouse SGLT2, IC50: 5.64 nM |
| S0993 |
Remogliflozin etabonate (GSK189075) |
Remogliflozin etabonate (GSK189075) is an orally active, selective and low-affinity inhibitor of sodium glucose cotransporter (SGLT2) with Ki of 1950 nM, 2140 nM, 43100 nM, 8570 nM for hSGLT2, rSGLT2, hSGLT1, rSGLT1, respectively. Remogliflozin etabonate exhibits antidiabetic efficacy in rodent models. |
Selective |
hSGLT2, Ki: 1950 nM; rSGLT2, Ki: 2140 nM |
| S2343 |
Phlorizin |
Phlorizin (Phloridzin) is a dihydrochalcone found in the bark of pear (Pyrus communis), apple, cherry and other fruit trees. Phlorizin is a non-selective SGLT inhibitor with Ki of 300 nM and 39 nM for hSGLT1 and hSGLT2, respectively. Phlorizin is also a Na+/K+-ATPase inhibitor. |
Pan |
hSGLT2, Ki: 39 nM |
| S2342 |
Phloretin (RJC 02792) |
Phloretin (RJC 02792, NSC 407292, Dihydronaringenin) is a dihydrochalcone found in apple tree leaves, which shows beneficial effects on diabetes. |
Pan |
|
